The Hyperlipidemia drugs in development market research report provides comprehensive information on the therapeutics under development for Hyperlipidemia, complete with analysis by stage of ...
LDL 1.2.4.4. AE/SE: Steatorrhea (Fatty Stool); Inc. risk of bile stone formation; May bind to drugs (Inc. Excretion of drugs) 1.2.4.5. AE/SE: Steatorrhea (Fatty Stool); Inc. risk of bile stone ...